News Quantified

IGMS – igm biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

IGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]

Analyzing How You Should Play Cigna (CI) Ahead of Q1 Earnings [Yahoo! Finance]

IGM Biosciences Insiders Placed Bullish Bets Worth US$992.2k [Yahoo! Finance]

IGM Biosciences, Inc. (NASDAQ: IGMS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.

IGM Biosciences Announces Refocusing of Sanofi Collaboration [Yahoo! Finance]

6.1%

BEAT

2.0%

BEAT

Form ARS IGM Biosciences, Inc. For: Dec 31

Form DEFA14A IGM Biosciences, Inc.

Form DEF 14A IGM Biosciences, Inc. For: Apr 26

Form 3 IGM Biosciences, Inc. For: Apr 14 Filed by: Harler Mary Beth

Form 8-K IGM Biosciences, Inc. For: Apr 17

Top News Gainers

9/17 Form 3 IGM Biosciences, Inc. For: Sep 17 Filed by: Neu Kelvin 32.7%

3/19 IGM Biosciences to Announce Fourth Quarter and Year-end 2019 Financial Results and Host Conference Call and Webcast on March 26, 2020 30.8%

3/4 IGM Biosciences (NASDAQ: IGMS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 16.1%

3/26 Q4/2019 12/31/2019 EPS -0.490 ZacksConsensus -0.440 ActVsEst (0.050) - Miss 9.6%

4/3 IGM Biosciences to Participate in Canaccord Genuity Horizons in Oncology Virtual Event 9.1%

3/11 IGM Biosciences (NASDAQ: IGMS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 9.0%

12/23 Hedge Funds Have Never Been This Bullish On IGM Biosciences, Inc. (IGMS) [Yahoo! Finance News] 7.2%

10/14 IGM Biosciences (NASDAQ: IGMS) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating and a $25.00 price target on the stock. 6.6%

12/11 Form 4 IGM Biosciences, Inc. For: Dec 09 Filed by: BEHRENS M KATHLEEN 6.6%

10/1 Form 4/A IGM Biosciences, Inc. For: Sep 17 Filed by: Topsoe Christina Teng 4.2%

Top News Decliners

9/18 Form 424B4 IGM Biosciences, Inc. -13.0%

9/26 Form 4 IGM Biosciences, Inc. For: Sep 24 Filed by: Topsoe Jakob Haldor -5.8%

2/14 IGM Biosciences (NASDAQ: IGMS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.6%

3/18 Sellas Life Sciences up 4% on encouraging nelipepimut-S data [Seeking Alpha] -4.2%

2/6 IGM Biosciences to Present at Two Upcoming Investor Conferences -4.2%

9/24 Form SC 13D IGM Biosciences, Inc. Filed by: Redmile Group, LLC -4.0%

9/20 Form 8-K IGM Biosciences, Inc. For: Sep 20 -3.7%

4/21 Form DEF 14A IGM Biosciences, Inc. For: Jun 09 -2.3%

4/3 Form 4 IGM Biosciences, Inc. For: Feb 05 Filed by: Redmile Group, LLC -1.8%

2/7 Form 4 IGM Biosciences, Inc. For: Feb 05 Filed by: Tahir Misbah -1.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day